Good morning :)
Add to Watchlist
Share

How to use scorecard? Learn more

Nippon India Pharma Fund Direct Growth

Growth
572.720.36% (+2.08)
High
Low
Returns
0.00%
0.00%
1M
6M
1Y
3Y
5Y
Max
SIP
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP

Equity

Sectoral Fund - Pharma & Health Care

Large-size Fund

Assets Under Mgmt: ₹ 8,259 Cr

Very High Risk

Principle investment will be at very high risk

How to use scorecard? Learn more

Equity

Sectoral Fund - Pharma & Health Care

Large-size Fund

Assets Under Mgmt: ₹ 8,259 Cr

Very High Risk

Principle investment will be at very high risk

Nippon India Pharma Fund Performance & Key Metrics

Nippon India Pharma Fund Performance & Key Metrics

Expense RatioExpense RatioNo LabelNo LabelNo LabelNo Label
0.8947.440.78
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.5053.390.69

Nippon India Pharma Fund Scheme InfoNippon India Pharma Fund Scheme Info

PlanPlanLock inLock inExit LoadExit Load
Growth0 yrs1.00%
1% on or before 1M Nil after 1M
SIP Inv.SIP Inv.Min. LumpsumMin. Lumpsum
Allowed₹ 5,000
Initial: ₹ 5,000 Incremental: ₹ 1,000
BenchmarkBenchmark
BSE Health Care - TRI

About Sectoral Fund - Pharma & Health Care

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

Nippon India Pharma Fund Peers

Nippon India Pharma Fund Peers & Comparison

Comparing 3 mutual funds from 
EquitySectoral Fund - Pharma & Health Care
Loading...
Mutual Fund1Y Returns1Y Returns3Y CAGR3Y CAGRLife CAGRLife CAGR
Nippon India Pharma Fund15.64%25.93%18.43%
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund25.00%30.21%23.26%
SBI Healthcare Opp Fund22.62%29.79%18.31%
DSP Healthcare Fund18.71%27.45%24.84%

Nippon India Pharma Fund Returns Comparison

Compare Nippon India Pharma Fund with any MF, ETF, stock or index
Compare Nippon India Pharma Fund with any MF, ETF, stock or index
Nippon India Pharma Fund
Hmm, looks like data is unavailable here. Please come back after some time
Loading...

Nippon India Pharma Fund Portfolio

Nippon India Pharma Fund Asset Allocation

Nippon India Pharma Fund Asset Allocation

Actual

Target

Sep 2024

Dec 2024

Mar 2025

May 2025

ACTUAL
Cash & EquivalentsEquity1.42%98.58%

Sep 2024

Dec 2024

Mar 2025

May 2025

Tickertape Separator

Nippon India Pharma Fund Sector Distribution

Nippon India Pharma Fund Sector Distribution

OthersMiscellaneousLabs & Life Sciences ServicesPharmaceuticals0.77 %1.52 %18.26 %79.45 %

Sep 2024

Dec 2024

Mar 2025

May 2025

Tickertape Separator

Nippon India Pharma Fund Sector Weightage

Nippon India Pharma Fund Sector Weightage

Mar 24Jun 24Sep 24Dec 24Mar 25May 2580.92%81.93%79.13%79.37%80.62%79.45%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

Nippon India Pharma Fund Current Holdings

Nippon India Pharma Fund Current Holdings

Equity

Others

  • Constituent
    Holding Weight
    3M Change

AMC Profile of Nippon India Pharma Fund

AMC Profile of Nippon India Pharma Fund

Nippon India Mutual Fund is one of India’s leading mutual funds, with Average Assets Under Management (AAUM) of Rs 2,79,431 Crores​​. NIMF has been established as a trust under the Indian Trusts Act, 1882 with Nippon Life Insurance Company as its Sponsor and Nippon Life India Trustee Ltd as its Trustee.

Nippon India Mutual Fund is one of India’s leading mutual funds, with Average Assets Under Management (AAUM) of Rs 2,79,431 Crores​​. NIMF has been established as a trust under the Indian Trusts Act, 1882 with Nippon Life Insurance Company as its Sponsor and Nippon Life India Trustee Ltd as its Trustee.

  • No.of Schemes

    79

  • Total AUM

    ₹ 4,49,487.71 Cr.

Nippon India Pharma Fund Manager Details

Nippon India Pharma Fund Manager Details

Nippon India Pharma Fund Manager Profile

Nippon India Pharma Fund Manager Profile

Sailesh Raj Bhan

AUM:  ₹93,492.92 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: 10yrs

Qualification

MBA (Finance), CFA (ICFAI)

Past Experience

Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

Funds Managed (6)
9.98%
9.98%
25.20%
25.20%
0.67%
0.67%
8.94%
8.94%
29.87%
29.87%
0.74%
0.74%
14.60%
14.60%
24.81%
24.81%
1.80%
1.80%
8.07%
8.07%
28.88%
28.88%
1.53%
1.53%
9.02%
9.02%
24.14%
24.14%
1.53%
1.53%
15.64%
15.64%
25.93%
25.93%
0.89%
0.89%

Nippon India Pharma Fund Manager Performance (0)

Nippon India Pharma Fund Manager Performance (0)

Loading...

Nippon India Pharma Fund Tax Implications

Nippon India Pharma Fund Tax Implications

Invested period < 1 year

Gains are treated as short-term capital gains and taxed at 20%

Invested period > 1 year

Gains are treated as long-term capital gains and taxed at 12.5%

Let’s calculate your returns after tax

Investment frequency

Monthly

One Time

Monthly Investment Amt. (₹)

Investment period (years)

CAGR (%)
This CAGR is calculated based on the actual past return given by the fund during the selected investment period. This is the annualised growth rate assuming monthly compounding.

+

-

You make

Nippon India Pharma Fund Review & Opinions

Nippon India Pharma Fund Review & Opinions

The content here in the form of articles and videos is for information purposes only and may have been sourced from publicly available sources or otherwise. Tickertape does not guarantee the authenticity and veracity of the material shared. The User understands and agrees that Tickertape is not aware nor liable for any content shared here.

Frequently asked questions

Frequently asked questions

  1. What is the current price / NAV of Nippon India Pharma Fund?

    The current NAV of Nippon India Pharma Fund is ₹572.72, as of 12th June 2025.

  2. What are the returns of Nippon India Pharma Fund?

    The Nippon India Pharma Fund was launched on 1st January 1970. This mutual fund's past returns are as follows:
    • 1 Year Returns: 15.64%
    • 3 Year Returns: 25.93%
    • 5 Year Returns: 23.15%

  3. What are the top 5 sectoral holdings of Nippon India Pharma Fund?

    The top sectors Nippon India Pharma Fund has invested in are as follows:
    • Pharmaceuticals | 79.45%
    • Labs & Life Sciences Services | 18.26%
    • Miscellaneous | 1.52%
    • Others | 0.77%
    This data is as on 12th June 2025.

  4. What are the top 5 holdings of Nippon India Pharma Fund?

    The top 5 holdings for Nippon India Pharma Fund are as follows:
    • Sun Pharmaceutical Industries Ltd | 12.57%
    • Divi's Laboratories Ltd | 9.49%
    • Lupin Ltd | 5.82%
    • Cipla Ltd | 5.62%
    • Dr Reddy's Laboratories Ltd | 5.49%
    This data is as on 12th June 2025.

  5. What is the asset allocation of Nippon India Pharma Fund?

    The asset allocation for Nippon India Pharma Fund is as follows:
    • Equity | 98.58%
    • Cash & Equivalents | 1.42%
    This data is as on 12th June 2025.

  6. What is the AUM of Nippon India Pharma Fund?

    The AUM (i.e. assets under management) of Nippon India Pharma Fund is ₹8259.60 Cr as of 12th June 2025.

  7. What is the expense ratio of Nippon India Pharma Fund?

    The expense ratio of Nippon India Pharma Fund Plan is 0.89 as of 12th June 2025.

  8. What is the alpha ratio of Nippon India Pharma Fund?

    The alpha ratio for the Nippon India Pharma Fund is -0.42

    Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.

  9. What is the volatility or standard deviation of Nippon India Pharma Fund?

    The volatility or standard deviation for the Nippon India Pharma Fund is 14.70

    Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

  10. What is the sharpe ratio of Nippon India Pharma Fund?

    The Sharpe ratio for the Nippon India Pharma Fund is 0.78

    The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

  11. What is the Sortino ratio of Nippon India Pharma Fund?

    The Sortino Ratio for the Nippon India Pharma Fund is 0.08

    The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.

  12. What is the Price to Earnings (PE) ratio of Nippon India Pharma Fund?

    The PE ratio of Nippon India Pharma Fund is 47.44, while category PE ratio is 53.39.